两周内主动脉扩张与B型急性主动脉综合征患者后续主动脉事件相关
这项回顾性单中心研究纳入183例无并发症B型急性主动脉综合征患者,按入院及出院前CT测量的主动脉直径变化分组。随访期间51例(28%)发生主动脉相关不良事件,36例(20%)出现中度主动脉扩张;中度扩张组无事件生存率显著低于无中度扩张组(1年48±9% vs 90±3%,P<.001)。多变量分析显示,中度主动脉扩张(亚风险比3.64,95%CI 2.08-6.35,P<.001)和入院时主动脉直径≥40 mm(亚风险比2.96,95%CI 1.60-5.48,P<.001)与主动脉相关不良事件相关。
要点
- 无并发症B型急性主动脉综合征患者随访中28%发生主动脉相关不良事件。
- 两周内主动脉直径扩张≥2 mm但<5 mm定义为中度扩张,占20%。
- 中度扩张组1年无事件生存率48±9%,低于无中度扩张组的90±3%。
核心结论
- 两周内中度主动脉扩张是无并发症B型急性主动脉综合征患者主动脉相关不良事件的显著危险因素。
- 作者认为,中度主动脉扩张患者应仔细随访,并可能成为后续血管内治疗的候选者。
研究设计与样本
- 回顾性单中心研究,纳入2010年至2019年诊断的无并发症B型急性主动脉综合征(经典主动脉夹层和壁内血肿)且在第2或第3周有随访CT的183例患者。
- 入院时和出院前随访时测量主动脉直径。
主要发现
- 随访期间51例(28%)发生主动脉相关不良事件,36例(20%)出现中度主动脉扩张。
- 中度主动脉扩张患者无主动脉相关事件生存率低于无中度扩张患者(1年48±9% vs 90±3%,P<.001)。
- 多变量分析中,中度主动脉扩张与主动脉相关不良事件相关(亚风险比3.64,95%CI 2.08-6.35,P<.001)。
- 多变量分析中,入院时主动脉直径≥40 mm与主动脉相关不良事件相关(亚风险比2.96,95%CI 1.60-5.48,P<.001)。
关键数值与推荐
- 中度主动脉扩张定义为两周内主动脉直径扩张≥2 mm但<5 mm。
- 主动脉相关不良事件定义为主动脉破裂、外科或血管内主动脉修复、再夹层、严重肠道灌注不良和主动脉扩张的复合终点。
临床怎么用
- 作者认为,中度主动脉扩张患者应仔细随访,并可能成为后续血管内治疗的候选者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine whether aortic enlargement in 2 weeks in patients with type B acute aortic syndrome is associated with aorta-related adverse events. METHODS: This retrospective, single-center study included 183 patients who were diagnosed with uncomplicated type B acute aortic syndrome (classic aortic dissection and intramural hematoma) between 2010 and 2019 and had follow-up computed tomography at second or third week. Aortic diameter was measured at admission and at predischarge follow-up. Aorta-related adverse events were defined by a composite of aortic rupture, surgical or endovascular aortic repair, redissection, severe intestinal malperfusion, and aortic enlargement. RESULTS: The patients whose aortic diameter enlarged ≥2 mm but <5 mm in 2 weeks were categorized as moderate aortic enlargement group. During follow-up, 51 patients (28%) had aorta-related adverse events and 36 patients (20%) had moderate aortic enlargement. Patients with moderate aortic enlargement showed lower aorta-related event-free survival rates than those without moderate enlargement (48 ± 9% vs 90 ± 3% at 1 year, P < .001). On multivariable analysis, moderate aortic enlargement (subhazard ratio, 3.64; 95% confidence interval, 2.08-6.35; P < .001) and aortic diameter ≥40 mm at admission (subhazard ratio, 2.96; 95% confidence interval, 1.60-5.48; P < .001) were associated with aorta-related adverse events. CONCLUSIONS: Moderate aortic enlargement in 2 weeks is a significant risk factor of aorta-related adverse events in patients with uncomplicated type B acute aortic syndrome. Patients with moderate aortic enlargement should be followed up carefully and may be candidates for subsequent endovascular treatment.
引用
- Miyoshi Y, Kaji S, Masumoto A, et al. Aortic enlargement in two weeks is associated with subsequent aortic events in patients with type B acute aortic syndrome. J Thorac Cardiovasc Surg. 2021. PMID: 34749934. doi:10.1016/j.jtcvs.2021.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。